KEYTRUDA plus chemotherapy is the first approval in the EU for an anti-PD-1 therapy combined with chemotherapy only for patients with primary advanced or recurrent endometrial carcinoma regardless ...

is effective and tolerable in heavily pre-treated patients with folate receptor alpha-positive (FRα+), platinum-sensitive ovarian cancer.

For a fertility workup in women, Dhillon-Smith relies on a pelvic ultrasound. She also measures ovarian reserve in the form of follicle-stimulating hormone, anti-mullerian hormone, and antral ...

The other is p53 abnormality. Papillary serous cancers are typically P53 mutated, but some other grade 3 endometrioids or other endometrioid clear cell cancers may be p53 mutated. Those patients ...

Renal cell carcinoma (RCC) is a common cancer that varies in clinical ... While most RCCs are detected on computed tomography (CT) scans, aggressiveness classification is based on pathology images ...

However, it is important to differentiate EV-associated proteins enriched in patients with pancreatic ductal adenocarcinoma (PDAC) from those with benign pancreatic diseases such as chronic ...

The incidence and survival of pancreatic cancer by histology, including rare subtypes ... Effects of alcohol drinking and smoking on pancreatic ductal adenocarcinoma mortality: A retrospective cohort ...